CyFlow CD103 PE (RUO)
| 品番 | AX666438 | ||
|---|---|---|---|
| 抗体名 | Anti-Hu CD103 PE,Ber-ACT8 | ||
| 包装単位 | 100 tests | ||
| 濃度 | - | ||
| 推奨使用量 | - | ||
| 容量 | 1 ml | ||
| 関連製品 (アイソタイプコントロール) |
Mouse IgG1 PE (BV655324) |
||
| 反応性|交差吸着 | Human | Non-Human Primates | レーザー | Blue, Green, Yellow |
| 抗原 | CD103, ITGAE | 最大蛍光波長 | 576 nm |
| クローン | Ber-ACT8 | 最大励起波長 | 496 nm, 565 nm |
| ホスト | Mouse | 標識/Format | PE |
| アイソタイプ | IgG1 | 研究分野 | Immunophenotyping |
| クローナリティ | monoclonal | アプリケーション | - |
Anti-Hu CD103 PE,Ber-ACT8
特異性
The mouse monoclonal antibody Ber-ACT8 recognizes CD103 antigen, a type I transmembrane glycoprotein primarily found on intestinal intraepithelial lymphocytes.
抗原情報
CD103 (Integrin αE) is an integrin subunit that is expressed on intraepithelial lymphocytes, epithelial dendritic cells, lamina propria-derived dendritic cells, a subpopulation of lamina propria T cells, a small subset of peripheral lymphocytes, namely T reg cells, and on activated and TGF-β stimulated lymphocytes. CD103 is in mature form cleaved into two disulfide-linked chains (C-terminal 150 kDa chain and N-terminal 25 kDa chain). It heterodimerizes with integrin β7 subunit to form αE/β7 integrin (mucosal lymphocyte 1 antigen), which through binding E-cadherin mediates homing of lymphocytes to the intestinal epithelium, and, in addition to the role in adhesion, may serve as an accessory molecule for intraepithelial lymphocyte activation.
利用方法
The reagent is designed for Flow Cytometry analysis of human blood cells. Recommended usage is 10 µl reagent / 100 µl of whole blood or 10^6 cells in a suspension. The content of a vial (1 ml) is sufficient for 100 tests.
保存方法
Avoid prolonged exposure to light. Store in the dark at 2-8°C. Do not freeze.
安定性情報
Do not use after expiration date stamped on vial label.
レファレンス
• Brandes M, Willimann K, Lang AB, Nam KH, Jin C, Brenner MB, Morita CT, Moser B: Flexible migration program regulates gamma delta T‑cell involvement in humoral immunity. Blood. 2003·Nov·15; 102(10):3693‑701. <·PMID:·12881309·>
• Cardoso CR, Garlet GP, Moreira AP, Júnior WM, Rossi MA, Silva JS: Characterization of CD4+CD25+ natural regulatory T cells in the inflammatory infiltrate of human chronic periodontitis. J·Leukoc·Biol. 2008·Jul; 84(1):311‑8. <·PMID:·18451325·>
• French JJ, Cresswell J, Wong WK, Seymour K, Charnley RM, Kirby JA: T cell adhesion and cytolysis of pancreatic cancer cells: a role for E‑cadherin in immunotherapy?. Br·J·Cancer. 2002·Oct·21; 87(9):1034‑41. <·PMID:·12434297·>
• Jaensson E, Uronen-Hansson H, Pabst O, Eksteen B, Tian J, Coombes JL, Berg PL, Davidsson T, Powrie F, Johansson-Lindbom B, Agace WW: Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans. J·Exp·Med. 2008·Sep·1; 205(9):2139‑49. <·PMID:·18710932·>
• Kost CB, Holden JT, Mann KP: Marginal zone B‑cell lymphoma: a retrospective immunophenotypic analysis. Cytometry·B·Clin·Cytom. 2008·Sep; 74(5):282‑6. <·PMID:·18500740·>
• Kost CB, Holden JT, Mann KP: Marginal zone B‑cell lymphoma: a retrospective immunophenotypic analysis. Cytometry·B·Clin·Cytom. 2008·Sep; 74(5):282‑6. <·PMID:·18500740·>
• León F, Roy G: Isolation of human small bowel intraepithelial lymphocytes by annexin V‑coated magnetic beads. Lab·Invest. 2004·Jun; 84(6):804‑9. <·PMID:·15154017·>
• Poles MA, Barsoum S, Yu W, Yu J, Sun P, Daly J, He T, Mehandru S, Talal A, Markowitz M, Hurley A, Ho D, Zhang L: Human immunodeficiency virus type 1 induces persistent changes in mucosal and blood gammadelta T cells despite suppressive therapy. J·Virol. 2003·Oct; 77(19):10456‑67. <·PMID:·12970431·>
• Sigmundsdottir H, Johnston A, Gudjonsson JE, Bjarnason B, Valdimarsson H: Methotrexate markedly reduces the expression of vascular E‑selectin, cutaneous lymphocyte‑associated antigen and the numbers of mononuclear leucocytes in psoriatic skin. Exp·Dermatol. 2004·Jul; 13(7):426‑34. <·PMID:·15217363·>
• Zhang L, Bertucci AM, Ramsey-Goldman R, Burt RK, Datta SK: Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF‑beta‑producing CD8+ Treg cells are associated with immunological remission of lupus. J·Immunol. 2009·Nov·15; 183(10):6346‑58. <·PMID:·19841178·>